13,14-Dehydro-15-cyclohexyl carbaprostacyclin, with the CAS number 145375-81-1, is a synthetic analog of prostacyclin, a potent vasodilator and inhibitor of platelet aggregation. This compound features a unique structure that includes a cyclohexyl group, which contributes to its biological activity. It is characterized by its ability to mimic the effects of natural prostacyclin, promoting vasodilation and potentially offering therapeutic benefits in conditions related to vascular health. The compound is typically studied for its pharmacological properties, including its role in cardiovascular function and its potential applications in treating pulmonary hypertension and other vascular disorders. Its stability, solubility, and reactivity are influenced by the presence of specific functional groups within its molecular structure. As with many synthetic analogs, the efficacy and safety profile of 13,14-dehydro-15-cyclohexyl carbaprostacyclin are subjects of ongoing research, particularly in the context of its therapeutic applications and mechanisms of action in biological systems.

13,14-DEHYDRO-15-CYCLOHEXYL CARBAPROSTACYCLIN

145375-81-1: 13,14-Dehydro-15-cyclohexyl carbaprostacyclin, with the CAS number 145375-81-1, is a synthetic analog of prostacyclin, a potent vasodilator and inhibitor of platelet aggregation. This compound features a unique structure that includes a cyclohexyl group, which contributes to its biological activity. It is characterized by its ability to mimic the effects of natural prostacyclin, promoting vasodilation and potentially offering therapeutic benefits in conditions related to vascular health. The compound is typically studied for its pharmacological properties, including its role in cardiovascular function and its potential applications in treating pulmonary hypertension and other vascular disorders. Its stability, solubility, and reactivity are influenced by the presence of specific functional groups within its molecular structure. As with many synthetic analogs, the efficacy and safety profile of 13,14-dehydro-15-cyclohexyl carbaprostacyclin are subjects of ongoing research, particularly in the context of its therapeutic applications and mechanisms of action in biological systems.

<p>13,14-dehydro-15-cyclohexyl Carbaprostacyclin, a stable PGI2 analog, impedes ADP-induced platelet aggregation; ED50 ~40 nM in PRP, 77 nM in washed platelets.</p>

CAS 145375-81-1

13,14-DEHYDRO-15-CYCLOHEXYL CARBAPROSTACYCLIN

13,14-dehydro-15-cyclohexyl Carbaprostacyclin

Ref: TM-T36774